|
Biomarker Testing and Interpretation after Breast Cancer Diagnosis |
0.75 |
03/15/2025 - 12:00am to 03/15/2026 - 12:00am |
|
Neoadjuvant/Adjuvant Treatment of Early-Stage Breast Cancer with SABCS Updates |
1.25 |
03/15/2025 - 12:00am to 03/15/2026 - 12:00am |
|
Updates to Radiation Therapy for Invasive Breast Cancer with SABCS Updates |
0.75 |
03/15/2025 - 12:00am to 03/15/2026 - 12:00am |
|
Surgical Management of DCIS and Invasive Breast Cancer with SABCS Updates |
0.50 |
03/15/2025 - 12:00am to 03/15/2026 - 12:00am |
|
Management of CNS Metastases in Patients with Breast Cancer |
0.75 |
03/15/2025 - 12:00am to 03/15/2026 - 12:00am |
|
Advances in the Management of Metastatic Breast Cancer with SABCS Updates |
1.25 |
03/15/2025 - 12:00am to 03/15/2026 - 12:00am |
|
Inequities in Clinical Outcomes in Breast Cancer: Do Biologic Differences Based on Ancestry/Racial Identity Play a Role? |
0.50 |
03/15/2025 - 12:00am to 03/15/2026 - 12:00am |
|
Survivorship Care for Patients Living with Metastatic Breast Cancer |
1.00 |
03/15/2025 - 12:00am to 03/15/2026 - 12:00am |
|
NCCN Guidelines® Insights - Testicular Cancer, Version 2.2025 |
1.00 |
04/10/2025 - 12:00am to 04/10/2026 - 12:00am |
|
Recorded Presentation from Optimizing Patient Outcomes - Metastatic Castration-Resistant Prostate Cancer: Systemic Therapy Updates |
1.00 |
05/02/2025 - 12:00am to 05/02/2026 - 12:00am |
|
Archived NCCN Tumor Boards: T-Cell Engager Therapy for Diffuse Large B-Cell Lymphoma: Bispecific Antibodies for Relapsed/Refractory Disease |
1.00 |
05/06/2025 - 12:00am to 04/30/2026 - 12:00am |
|
NCCN Guidelines® Insights - Multiple Myeloma, Version 1.2025 |
1.00 |
05/10/2025 - 12:00am to 05/10/2026 - 12:00am |
|
Recorded Presentation from Optimizing Patient Outcomes - Targeted Therapies for Thyroid Carcinoma |
1.00 |
05/27/2025 - 12:00am to 05/27/2026 - 12:00am |
|
Archived NCCN Tumor Boards: New Approaches to the Management of Resectable Non-Small Cell Lung Cancer |
1.00 |
05/28/2025 - 12:00am to 05/22/2026 - 11:59pm |
|
Archived NCCN Tumor Boards: Treatment Options and Navigating Sequencing of Therapies in Relapsed/Refractory Multiple Myeloma |
1.00 |
05/28/2025 - 12:00am to 05/23/2026 - 11:59pm |